Founder of EOS SpA, Jacques Theurillat is a Swiss businessperson who has been at the helm of 7 different companies and presently occupies the position of Chairman for Vifor Pharma AG, Chairman for Vifor Pharma Management AG (a subsidiary of Vifor Pharma AG) and Partner at Sofinnova Partners SAS.

He is also on the board of Mundipharma, Inc., Napp Pharmaceutical Holdings Ltd., ADC Therapeutics SA and CNH Industrial NV and Partner at Sofinnova Crossover Fund.

In his past career Jacques Theurillat held the position of Chairman & Chief Executive Officer of AlbeaPharma AG, Chairman & Chief Executive Officer of Albea Pharmaceuticals AG, Managing Director at Istituto Farmacologico Serono, Chief Executive Officer for Ares Life Sciences AG, Deputy Chairman of Esaote SpA, Managing Partner at Campus Holding SA and CFO & Deputy Chief Executive Officer at Serono SA.

He received a graduate degree from the University of Geneva, a graduate degree from Madrid University and an MBA from Centro de Estudios Financieros.